NEW YORK, Oct. 18, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Europe Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery

http://www.reportlinker.com/p0739466/Europe-Diabetes-Care-Devices-Market...

Europe Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery

Summary

GlobalData's new report, "Europe Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery" provides key market data on the Europe Diabetes Care Devices market – Germany, France, Italy, Spain and United Kingdom.. The report provides value (USD million) data for all the market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Countries covered include Germany, France, Italy, Spain and United Kingdom..

- Market size and company share data for Diabetes Care Devices market categories – Insulin Delivery and Glucose Monitoring.

- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.

- 2011 company shares and distribution shares data for each of the market categories and countries.

- Global corporate-level profiles of key companies operating within the Europe Diabetes Care Devices market.

- Key players covered include F. Hoffmann-La Roche Ltd., Sanofi, Novo Nordisk A/S, Eli Lilly and Company, LifeScan, Inc., Medtronic, Inc., Bayer HealthCare AG, Becton, Dickinson and Company, Abbott Laboratories, Animas Corporation and Ypsomed Holding AG.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Europe Diabetes Care Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 8

2 Introduction 9

2.1 What is This Report About? 9

3 Diabetes Care Devices in Europe 10

3.1 Diabetes Care Devices Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 10

3.2 Diabetes Care Devices, Europe, Overall Revenue ($m), USD Constant, 2004-2018 11

3.3 Diabetes Care Devices, Europe, Company share (2010-2011) 16

4 Diabetes Care Devices In Germany 18

4.1 Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, 2004-2018 18

4.2 Diabetes Care Devices, Germany, Distribution Share (2010-2011) 23

4.2.1 Glucose Monitoring, Germany, Distribution Share (2010-2011) 23

4.2.2 Insulin Delivery, Germany, Distribution Share (2010-2011) 23

4.3 Diabetes Care Devices, Germany, Company Share (2010-2011) 24

4.3.1 Diabetes Care Devices, Germany, Company Share (2010-2011) 24

4.3.2 Glucose Monitoring, Germany, Company Share (2010-2011) 26

4.3.3 Insulin Delivery, Germany, Company Share (2010-2011) 28

5 Diabetes Care Devices In France 30

5.1 Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, 2004-2018 30

5.2 Diabetes Care Devices, France, Distribution Share (2010-2011) 35

5.2.1 Glucose Monitoring, France, Distribution Share (2010-2011) 35

5.2.2 Insulin Delivery, France, Distribution Share (2010-2011) 35

5.3 Diabetes Care Devices, France, Company Share (2010-2011) 36

5.3.1 Diabetes Care Devices, France, Company Share (2010-2011) 36

5.3.2 Glucose Monitoring, France, Company Share (2010-2011) 38

5.3.3 Insulin Delivery, France, Company Share (2010-2011) 40

6 Diabetes Care Devices In United Kingdom 42

6.1 Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 42

6.2 Diabetes Care Devices, United Kingdom, Distribution Share (2010-2011) 47

6.2.1 Glucose Monitoring, United Kingdom, Distribution Share (2010-2011) 47

6.2.2 Insulin Delivery, United Kingdom, Distribution Share (2010-2011) 47

6.3 Diabetes Care Devices, United Kingdom, Company Share (2010-2011) 48

6.3.1 Diabetes Care Devices, United Kingdom, Company Share (2010-2011) 48

6.3.2 Glucose Monitoring, United Kingdom, Company Share (2010-2011) 50

6.3.3 Insulin Delivery, United Kingdom, Company Share (2010-2011) 52

7 Diabetes Care Devices In Italy 54

7.1 Diabetes Care Devices, Italy, Overall Revenue ($m), USD Constant, 2004-2018 54

7.2 Diabetes Care Devices, Italy, Distribution Share (2010-2011) 59

7.2.1 Glucose Monitoring, Italy, Distribution Share (2010-2011) 59

7.2.2 Insulin Delivery, Italy, Distribution Share (2010-2011) 59

7.3 Diabetes Care Devices, Italy, Company Share (2010-2011) 60

7.3.1 Diabetes Care Devices, Italy, Company Share (2010-2011) 60

7.3.2 Glucose Monitoring, Italy, Company Share (2010-2011) 62

7.3.3 Insulin Delivery, Italy, Company Share (2010-2011) 64

8 Diabetes Care Devices In Spain 66

8.1 Diabetes Care Devices, Spain, Overall Revenue ($m), USD Constant, 2004-2018 66

8.2 Diabetes Care Devices, Spain, Distribution Share (2010-2011) 71

8.2.1 Glucose Monitoring, Spain, Distribution Share (2010-2011) 71

8.2.2 Insulin Delivery, Spain, Distribution Share (2010-2011) 71

8.3 Diabetes Care Devices, Spain, Company Share (2010-2011) 72

8.3.1 Diabetes Care Devices, Spain, Company Share (2010-2011) 72

8.3.2 Glucose Monitoring, Spain, Company Share (2010-2011) 74

8.3.3 Insulin Delivery, Spain, Company Share (2010-2011) 76

9 Overview of Key Companies in Europe Diabetes Care Devices Market 78

9.1 F. Hoffmann-La Roche Ltd. 78

9.1.1 Company Overview 78

9.1.2 Share in the Europe Diabetes Care Devices Market 78

9.2 Sanofi 79

9.2.1 Company Overview 79

9.2.2 Share in the Europe Diabetes Care Devices Market 79

9.3 Novo Nordisk A/S 80

9.3.1 Company Overview 80

9.3.2 Share in the Europe Diabetes Care Devices Market 80

9.4 Eli Lilly and Company 81

9.4.1 Company Overview 81

9.4.2 Share in the Europe Diabetes Care Devices Market 81

9.5 LifeScan, Inc. 82

9.5.1 Company Overview 82

9.5.2 Share in the Europe Diabetes Care Devices Market 82

9.6 Medtronic, Inc. 83

9.6.1 Company Overview 83

9.6.2 Share in the Europe Diabetes Care Devices Market 83

9.7 Bayer HealthCare AG 84

9.7.1 Company Overview 84

9.8 Becton, Dickinson and Company 84

9.8.1 Company Overview 84

9.9 Abbott Laboratories 85

9.9.1 Company Overview 85

9.10 Animas Corporation 85

9.10.1 Company Overview 85

9.11 Ypsomed Holding AG 86

9.11.1 Company Overview 86

9.12 Arkray, Inc. 86

9.12.1 Company Overview 86

9.13 Nipro Corporation 87

9.13.1 Company Overview 87

9.14 B. Braun Melsungen AG 87

9.14.1 Company Overview 87

9.15 Terumo Corporation 88

9.15.1 Company Overview 88

10 Diabetes Care Devices Market Pipeline Products 89

11 Financial Deals Landscape 92

11.1 Partnerships 92

11.1.1 Insulet Expands Distribution Agreement With Ypsomed Holding 92

11.1.2 Insulet Amends Licensing Agreement With Abbott Diabetes 93

11.1.3 Mendor Enters Into Distribution Agreement With Merck Serono 94

12 Recent Developments 95

12.1 Strategy And Business Planning 95

12.1.1 Sep 05, 2012: Roche Provides Update On Its Strategy At Investor Conference 95

12.1.2 Jun 26, 2012: Roche To Shut New Jersey Site, Eliminate 1,000 Jobs 96

12.1.3 Nov 02, 2011: Sanofi To Shut Down R&D Site In Bridgewater, New Jersey 97

12.1.4 Oct 13, 2011: Unisense Establishes US Headquarter 97

12.2 Government and Public Interest 98

12.2.1 May 23, 2012: Beta Cell Imaging Could Help Spot Diabetes Earlier: Vanderbilt University 98

13 Appendix 100

13.1 Definitions of Markets Covered in the Report 101

13.1.1 Diabetes Care Devices 101

13.2 Research Methodology 102

13.3 Secondary Research 102

13.4 Primary Research 102

13.5 Models 103

13.6 Forecasts 103

13.7 Expert Panels 103

13.8 GlobalData Consulting 104

13.9 Currency Conversion 104

13.10 Contact Us 104

13.11 Disclaimer 104

1.1 List of Tables

Table 1: Diabetes Care Devices, Cross Country Comparison, Revenue ($m),USD Constant, 2004-2018 10

Table 2: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Constant, 2004-2018 11

Table 3: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Constant, Historic, 2004-2011 13

Table 4: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 15

Table 5: Diabetes Care Devices, Europe, Company share by Revenue ($m), USD Constant, 2010-2011 17

Table 6: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, 2004-2018 18

Table 7: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, Historic, 2004-2011 20

Table 8: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 22

Table 9: Glucose Monitoring, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011 23

Table 10: Insulin Delivery, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-2011 23

Table 11: Diabetes Care Devices, Germany, Company Share, USD Constant, (2010-2011) 25

Table 12: Glucose Monitoring, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011 27

Table 13: Insulin Delivery, Germany, Company Share by Revenue ($m), USD Constant, 2010-2011 29

Table 14: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, 2004-2018 30

Table 15: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, Historic, 2004-2011 32

Table 16: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 34

Table 17: Glucose Monitoring, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011 35

Table 18: Insulin Delivery, France, Distribution Share by Revenue ($m), USD Constant, 2010-2011 35

Table 19: Diabetes Care Devices, France, Company Share, USD Constant, (2010-2011) 37

Table 20: Glucose Monitoring, France, Company Share by Revenue ($m), USD Constant, 2010-2011 39

Table 21: Insulin Delivery, France, Company Share by Revenue ($m), USD Constant, 2010-2011 41

Table 22: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 42

Table 23: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, Historic, 2004-2011 44

Table 24: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 46

Table 25: Glucose Monitoring, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 47

Table 26: Insulin Delivery, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2010-2011 47

Table 27: Diabetes Care Devices, United Kingdom, Company Share, USD Constant, (2010-2011) 49

Table 28: Glucose Monitoring, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 51

Table 29: Insulin Delivery, United Kingdom, Company Share by Revenue ($m), USD Constant, 2010-2011 53

Table 30: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Constant, 2004-2018 54

Table 31: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Constant, Historic, 2004-2011 56

Table 32: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 58

Table 33: Glucose Monitoring, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011 59

Table 34: Insulin Delivery, Italy, Distribution Share by Revenue ($m), USD Constant, 2010-2011 59

Table 35: Diabetes Care Devices, Italy, Company Share, USD Constant, (2010-2011) 61

Table 36: Glucose Monitoring, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011 63

Table 37: Insulin Delivery, Italy, Company Share by Revenue ($m), USD Constant, 2010-2011 65

Table 38: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Constant, 2004-2018 66

Table 39: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Constant, Historic, 2004-2011 68

Table 40: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 70

Table 41: Glucose Monitoring, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011 71

Table 42: Insulin Delivery, Spain, Distribution Share by Revenue ($m), USD Constant, 2010-2011 71

Table 43: Diabetes Care Devices, Spain, Company Share, USD Constant, (2010-2011) 73

Table 44: Glucose Monitoring, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011 75

Table 45: Insulin Delivery, Spain, Company Share by Revenue ($m), USD Constant, 2010-2011 77

Table 46: Diabetes Care DevicesMarket Pipeline Products 89

Table 47: Insulet Expands Distribution Agreement With Ypsomed Holding 92

Table 48: Insulet Amends Licensing Agreement With Abbott Diabetes 93

Table 49: Mendor Enters Into Distribution Agreement With Merck Serono 94

1.2 List of Figures

Figure 1: Diabetes Care Devices, Cross Country Comparison, Revenue ($m), USD Constant, 2004-2018 10

Figure 2: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Constant, 2004-2018 11

Figure 3: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Constant, Historic, 2004-2011 12

Figure 4: Diabetes Care Devices, Europe, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 14

Figure 5: Diabetes Care Devices, Europe, Company share (%), 2011 16

Figure 6: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, 2004-2018 18

Figure 7: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, Historic, 2004-2011 19

Figure 8: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 21

Figure 9: Diabetes Care Devices, Germany, Company Share (%), 2011 24

Figure 10: Glucose Monitoring, Germany, Company Share (%), 2011 26

Figure 11: Insulin Delivery, Germany, Company Share (%), 2011 28

Figure 12: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, 2004-2018 30

Figure 13: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, Historic, 2004-2011 31

Figure 14: Diabetes Care Devices, France, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 33

Figure 15: Diabetes Care Devices, France, Company Share (%), 2011 36

Figure 16: Glucose Monitoring, France, Company Share (%), 2011 38

Figure 17: Insulin Delivery, France, Company Share (%), 2011 40

Figure 18: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, 2004-2018 42

Figure 19: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, Historic, 2004-2011 43

Figure 20: Diabetes Care Devices, United Kingdom, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 45

Figure 21: Diabetes Care Devices, United Kingdom, Company Share (%), 2011 48

Figure 22: Glucose Monitoring, United Kingdom, Company Share (%), 2011 50

Figure 23: Insulin Delivery, United Kingdom, Company Share (%), 2011 52

Figure 24: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Constant, 2004-2018 54

Figure 25: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Constant, Historic, 2004-2011 55

Figure 26: Diabetes Care Devices, Italy, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 57

Figure 27: Diabetes Care Devices, Italy, Company Share (%), 2011 60

Figure 28: Glucose Monitoring, Italy, Company Share (%), 2011 62

Figure 29: Insulin Delivery, Italy, Company Share (%), 2011 64

Figure 30: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Constant, 2004-2018 66

Figure 31: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Constant, Historic, 2004-2011 67

Figure 32: Diabetes Care Devices, Spain, Overall Revenue ($m), USD Constant, Forecast, 2011-2018 69

Figure 33: Diabetes Care Devices, Spain, Company Share (%), 2011 72

Figure 34: Glucose Monitoring, Spain, Company Share (%), 2011 74

Figure 35: Insulin Delivery, Spain, Company Share (%), 2011 76

Figure 36: F. Hoffmann-La Roche Ltd., Company Share (%), Europe Diabetes Care Devices Market, 2011 78

Figure 37: Sanofi, Company Share (%), Europe Diabetes Care Devices Market, 2011 79

Figure 38: Novo Nordisk A/S Company Share (%), Europe Diabetes Care Devices Market, 2011 80

Figure 39: Eli Lilly and Company, Company Share (%), Europe Diabetes Care Devices Market, 2011 81

Figure 40: LifeScan, Inc., Company Share (%), Europe Diabetes Care Devices Market, 2011 82

Figure 41: Medtronic, Inc., Company Share (%), Europe Diabetes Care Devices Market, 2011 83

Companies mentioned

F. Hoffmann-La Roche Ltd.

Sanofi

Novo Nordisk A/S

Eli Lilly and Company

LifeScan, Inc.

Medtronic, Inc.

Bayer HealthCare AG

Becton, Dickinson and Company

Abbott Laboratories

Animas Corporation

Ypsomed Holding AG

Arkray, Inc.

Nipro Corporation

To order this report:

Pathology Industry: Europe Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery

Contact Nicolas: nicolasbombourg@reportlinker.com
US: (805)-652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker